Gunilla Lundmark

Gunilla Lundmark is currently the CEO of Uppsala universitet Invest AB, overseeing the commercialization of research findings from Uppsala University. They have served as a board member for several organizations, including Lipidor AB, SampleFacts, and Chordate Medical Holding AB. Previously, Gunilla held significant leadership roles at Q-Med, Pharmanest AB, and Pharmacia and Upjohn, managing large teams and spearheading product development across the pharmaceutical and medical device sectors. Gunilla holds both a BSc and an Executive MBA from Uppsala University.